Olanzapine NDC 13668-089

NDC codes

FDA NDC Directory

Product NDC (as listed)13668-089Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13668-0089Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
13668-089-05	13668008905	500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-089-05)Marketed from Oct 25, 2011
13668-089-30	13668008930	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-089-30)Marketed from Oct 25, 2011
13668-089-90	13668008990	90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-089-90)Marketed from Oct 25, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olanzapine
Generic name (nonproprietary): olanzapine
Active ingredients: Olanzapine — 15 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Torrent Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091415
Marketing start: Oct 25, 2011
Listing expires: Dec 31, 2027
Identifiers: Product ID 13668-089_1a64829a-2434-4c8d-8e58-9b28758e4b88SPL ID 1a64829a-2434-4c8d-8e58-9b28758e4b88SPL set ID 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15RxCUI 200034, 283639, 312076, 312077, 312078, 312079, 314154, 314155, 351107, 351108UNII N7U69T4SZRUPC 0313668088304, 0313668170306, 0313668169300, 0313668171303, 0313668168303, 0313668166309, 0313668090307, 0313668089301, 0313668167306, 0313668086300
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413668008905 followed by a unit qualifier and the quantity

Package 13668-0089-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Olanzapine is an atypical antipsychotic indicated: As oral formulation for the: • Treatment of schizophrenia. ( 1.1 ) • Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial. ( 14.1 ) • Adolescents (ages 13 to 17): Efficacy was established in one 6-week trial in patients with schizophrenia ( 14.1 ). The increased potential (in adolescents compared with adults) for weight gain and dyslipidemia may lead clinicians to consider prescribing other drugs first in adolescents. ( 1.1 ) • Acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. ( 1.2 ) •…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091415

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091415
Product	Strength	Form · route	Labeler	Product NDC
Olanzapine	Olanzapine 10 mg/1	Tablet, Orally disintegratingOral	Torrent Pharmaceuticals Limited	13668-088
Olanzapine	Olanzapine 5 mg/1	Tablet, Orally disintegratingOral	Torrent Pharmaceuticals Limited	13668-086
Olanzapine	Olanzapine 20 mg/1	Tablet, Orally disintegratingOral	Torrent Pharmaceuticals Limited	13668-090